Correlation of YMDD mutation and breakthrough hepatitis with hepatitis B virus DNA and serum ALT during lamivudine treatment-Reference-Cited by-同舟云学术

Correlation of YMDD mutation and breakthrough hepatitis with hepatitis B virus DNA and serum ALT during lamivudine treatment

Published:2010-02 Issue:2 Volume:40 Page:125-134
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:

Author:

Kobayashi Mariko,Suzuki Fumitaka,Akuta Norio,Yatsuji Hiromi,Hosaka Tetsuya,Sezaki Hitomi,Kobayashi Masahiro,Kawamura Yusuke,Suzuki Yoshiyuki,Arase Yasuji,Ikeda Kenji,Mineta Rie,Iwasaki Satomi,Watahiki Sachiyo,Kumada Hiromitsu

Publisher

Wiley

Subject

Infectious Diseases,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1872-034X.2009.00565.x/fullpdf

Reference23 articles.

1. Lamivudine as initial treatment for chronic hepatitis b in the United states;Dienstag;N Engl J Med,1999

2. Lamivudine is effective in suppressing hepatitis B virus DNA in Chinese hepatitis B surface antigen carriers: a placebo-controlled trial;Lai;Hepatology,1997

3. Lamivudine therapy for chronic hepatitis B: a six-month randomized dose-ranging study;Nevens;Gastroenterology,1997

4. Histological changes in liver biopsies after one year of lamivudine treatment in patients with chronic hepatitis B infection;Suzuki;J Hepatol,1999

5. Character of HBV (hepatitis B virus) polymerase gene rtM204V/I and rtL180M mutation in patients with lamivudine resistance;Li;J Zhejiang Univ Sci B,2005

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Elimination of the hepatitis B virus: A goal, a challenge;Medicinal Research Reviews;2024-03-25

2. Evaluation of Lamivudine Resistance Mutations in HBV/HIV Co-infected Patients;Iranian Journal of Medical Microbiology;2022-01-01

3. Dynamic profile of the HBeAg-anti-HBe system in acute and chronic hepatitis B virus infection: A clinical-laboratory approach;Molecular Biology Reports;2020-12-09

4. Endoplasmic reticulum-mediated induction of interleukin-8 occurs by hepatitis B virus infection and contributes to suppression of interferon responsiveness in human hepatocytes;Virology;2018-12

5. The association between serum cytokine and chemokine levels and antiviral response by entecavir treatment in chronic hepatitis B patients;Antiviral Therapy;2017